Skip to main content
v2026.11,986 entries · CC-BY 4.0
LAC HealthSponsored

Shop immunoassay analyzer supplies

  • FDA registered
  • ISO 13485
  • BBB Accredited A+

Shop at LAC Health

Immunoassay Analyzer: Types, Specs, and Selection

A clinical reference on immunoassay analyzer operating principles, detection types, manufacturer specs, CLSI validation standards, and selection criteria.

Written and maintained by CASRAI Editorial Board

Published · Last updated

This page describes products and general use; it is not medical advice.

On this page

Who uses it: Medical laboratory scientists, clinical pathologists, biomedical researchers, and clinical laboratory procurement teams.

What It Is

An immunoassay analyzer is an automated laboratory instrument designed to detect and quantify target analytes—such as hormones, cardiac biomarkers, infectious disease antibodies, tumor markers, and therapeutic drugs—in biological fluids including serum, plasma, urine, and whole blood.

The analyzer automates multi-step biochemical assays by coupling antibody-antigen binding to optical, chemiluminescent, or electrochemical detection. Modern systems manage sample aliquoting, reagent dispensing, incubation, separation, and bidirectional LIS reporting.

Under FDA regulations (21 CFR § 862.2160), automated immunoassay systems fall under Discrete photometric chemistry analyzer for clinical use (Class I, Product Code JJE). In laboratories governed by CLIA ’88 (42 CFR Part 493), automated immunoassay testing operates under Moderate or High Complexity categories, requiring formal CLIA certification, personnel qualification, and daily quality control.

How It Works or Is Built

Immunoassay analyzers quantify target molecules using antibody-antigen binding via two primary formats:

  • Sandwich (Non-Competitive) Assays: For large multi-epitope analytes (such as TSH, troponin, and viral antigens). The analyte is bound between a capture antibody and a labeled detection antibody; signal intensity is directly proportional to analyte concentration.
  • Competitive Assays: For small molecules and haptens (such as cortisol and therapeutic drugs) unable to bind two antibodies simultaneously. Endogenous analyte competes with labeled reagent analyte for limited antibody sites; signal intensity is inversely proportional to concentration.

Analyzers integrate six mechanical and optical subsystems:

  1. Sample Handling: Robotic arms handle primary blood tubes and cups, using capacitive liquid level sensing and pressure transducers for clot detection.
  2. Reagent Carousel: Climate-controlled storage (2 °C to 10 °C) holding packs formulated with monoclonal vs polyclonal antibodies for target specificity.
  3. Incubation Unit: Maintained at 37.0 °C ± 0.3 °C for stable binding kinetics.
  4. Separation and Wash Station: Magnets pull superparamagnetic particles to cuvette walls while probes wash unbound matrix using pure Type I laboratory water.
  5. Optical Detection Module: Light-tight housing with a photomultiplier tube (PMT) or photodiode measuring photon emission or absorbance.
  6. Data Engine: Translates raw optical signals into concentrations using four-parameter logistic (4PL) curve fitting against stored calibrators.

Types and Variants

Immunoassay analyzers are categorized by detection chemistry, which determines sensitivity, dynamic range, and turnaround speed.

Type Typical Use Key Difference
Chemiluminescent Immunoassay (CLIA / CMIA) Routine endocrinology, high-sensitivity cardiac troponin, oncology markers, therapeutic drugs. Chemical oxidation (acridinium ester or ALP/dioxetane) emits light; wide dynamic range without external excitation lamps.
Electrochemiluminescence (ECLIA / ECL) Emergency STAT cardiac markers, reproductive hormones, infectious disease serology. Electrical voltage triggers redox cycling between ruthenium [Ru(bpy)3]2+ and tripropylamine, enabling 9-minute STAT turnaround.
Automated Enzyme Immunoassay (EIA / ELISA) Infectious disease screening, autoimmune antibodies, specialty allergy panels. Enzyme cleavage produces colorimetric absorbance changes; open-reagent flexibility with microplate compatibility.
Fluoroimmunoassay (FIA / TR-FIA) Neonatal screening, prenatal screening, pediatric diagnostic panels. Pulsed excitation of long-decay lanthanide chelates; temporal delay filters out biological autofluorescence.

Sizes or Specifications That Matter

Footprint, loading mechanism, and throughput distinguish benchtop units from high-volume floor analyzers. Verified manufacturer specifications include:

Model & Manufacturer Form Factor Throughput Sample & Reagent Capacity Dimensions & Weight Source
Access 2 (Beckman Coulter) Benchtop Up to 100 tests/hr 60 samples; 24 refrigerated reagent packs 99 cm W × 61 cm D × 47 cm H; 91 kg Beckman Coulter Access 2 IFU
cobas e 411 (Roche Diagnostics) Benchtop / Compact Up to 86–88 tests/hr (9-min STAT) 30 samples (disk) / 75 (rack); 18 reagent packs 120 cm W × 73 cm D × 56–80 cm H; 170–180 kg Roche cobas e 411 Operator Manual
ARCHITECT i2000SR (Abbott) Floor-standing Up to 200 tests/hr 135 samples (35 STAT); 25 refrigerated packs 154.9 cm W × 124.5 cm D × 121.9 cm H; 490.3 kg Abbott ARCHITECT Operations Manual

Key analytical specifications to verify during procurement include:

  • Sample Volume: Typical assays draw 5 µL to 50 µL per test, preserving volume in pediatric collections.
  • Detection Capability: Verified under CLSI EP17-A2 for Limit of Blank (LoB), Limit of Detection (LoD), and Limit of Quantitation (LoQ). Establishing true analytical sensitivity is essential for high-sensitivity cardiac troponin.
  • Utility Demands: Floor units require dedicated 200–240 V electrical circuits, drainage lines, and pure water systems (15–30 L/hr).

How to Choose

Selecting an analyzer requires matching throughput, menu breadth, and analytical performance to laboratory workload and regulatory standards.

Selection Criterion Clinical or Operational Impact Verification Standard / Requirement
Assay Menu Breadth Determines whether a single platform consolidates routine thyroid, cardiac, oncology, and serology panels. Evaluate manufacturer assay menu and closed vs. open-system reagent architecture (Manufacturer IFU).
Analytical Precision Ensures repeatable results across runs, reagent lots, and calibration cycles. Within-laboratory precision (%CV < 5%) verified over 20 operating days per CLSI EP05-A3.
Reportable Range & Linearity Minimizes manual offline dilutions for elevated clinical samples. Dilution verification across the analytical measurement range per CLSI EP06.
Interference Robustness Prevents false reporting due to hemolysis, icterus, lipemia, or medications. Paired-difference interferent testing per CLSI EP07 guidelines.
STAT Turnaround Speed Supports critical emergency department decision-making for acute chest pain markers. Dedicated STAT priority lanes with assay cycles ≤ 10 minutes (e.g., Roche ECL / Abbott CMIA).
Facility Infrastructure Prevents structural overloading, power interruption, or water starvation. Site prep confirmation: floor load tolerance (up to 500 kg), HVAC sizing, and Type I water plumbing.

Safe Use and Handling Basics

Clinical immunoassay analyzers process human specimens handled under Universal Precautions per OSHA Bloodborne Pathogens standards (29 CFR 1910.1030) and CDC guidelines:

  • Biohazard Containment: Operators must wear PPE (gloves, lab coats, eye protection). Safety shields must remain closed during operation to contain aerosols.
  • Specimen Preparation: Blood tubes require centrifugation (1,300 to 2,000 × g for 10 minutes) and inspection for fibrin clots before loading. Incomplete clotting generates micro-fibrin strands that plug sampling probes.
  • Daily Maintenance: Routine protocols require cleaning probe exteriors with deproteinizing solution or 0.5% sodium hypochlorite followed by pure water. Wash stations must be inspected for crystalline salt buildup.
  • Quality Control Regimens: Running multi-level commercial controls (normal and abnormal ranges) is mandatory before releasing patient results, evaluated using standard Westgard multirules.
  • Liquid Waste Management: Analyzer fluidic waste contains biological proteins mixed with chemical triggers, requiring disposal via designated biohazard drain lines or neutralization containers.

Common Mistakes

Routine operations encounter several technical and biochemical pitfalls that distort immunoassay measurements:

  • Overlooking the High-Dose Hook Effect: In sandwich assays, massive analyte excess saturates capture and detection antibodies separately, preventing complete sandwich formation and causing falsely low results. Confirm clinically discordant results with serial dilutions.
  • Ignoring Biotin (Vitamin B7) Interference: High-dose dietary biotin (> 5 mg/day) binds streptavidin-coated magnetic particles, displacing biotinylated antibodies. This falsely lowers sandwich assay results (e.g., TSH, troponin) and falsely elevates competitive assay results (e.g., free T4, cortisol).
  • Failing to Account for Heterophilic Antibodies: Human anti-mouse antibodies (HAMA) or non-specific heterophiles can bridge assay antibodies without analyte, generating false-positive signals. Discordant specimens require testing in heterophile-blocking tubes.
  • Aspirating Fibrin Clots: Testing incompletely clotted serum obstructs sample probes. When clot sensors abort an aspiration, recentrifuge the tube rather than repeatedly restarting the test.
  • Neglecting Wash Station Maintenance: Clogged aspiration nozzles leave unwashed tracer conjugates in reaction cuvettes, elevating the analytical Limit of Blank and degrading low-end precision.

FAQ

What is the difference between a clinical chemistry analyzer and an immunoassay analyzer?

Clinical chemistry analyzers measure high-concentration metabolites (e.g., glucose, creatinine) at mg/dL levels photometrically or electrochemically. Immunoassay analyzers use antibody-antigen binding to measure low-concentration macromolecules and hormones at ng/mL or pg/mL levels.

How does a competitive immunoassay differ from a sandwich immunoassay?

A sandwich immunoassay traps the analyte between two antibodies, producing a signal directly proportional to analyte concentration for large multi-epitope molecules. A competitive immunoassay forces patient analyte to compete with labeled reagent analyte for limited antibody sites, producing a signal inversely proportional to concentration for small haptens.

What causes the hook effect on an automated immunoassay analyzer?

The hook effect occurs in sandwich assays when extreme analyte excess saturates both capture and detection antibodies separately, preventing complete sandwich formation and causing a paradoxically low signal.

What grade of laboratory water is required for automated immunoassay analyzers?

Analyzers require Type I clinical reagent water (≥ 10 MΩ·cm resistivity at 25 °C) to prevent trace contaminants from degrading wash buffers and generating background noise.

How does dietary biotin interfere with immunoassay results?

In streptavidin-biotin systems, free circulating biotin binds solid-phase streptavidin, blocking biotinylated antibody complexes. This causes falsely low readings in sandwich assays and falsely high readings in competitive assays.

Sources

  • Food and Drug Administration (FDA). 21 CFR § 862.2160: Discrete photometric chemistry analyzer for clinical use. openFDA. Accessed 2026-11-09. URL: https://api.fda.gov/device/classification.json?search=regulation_number:862.2160
  • Beckman Coulter Diagnostics. Access 2 Immunoassay System Instructions for Use. Accessed 2026-11-09. URL: https://www.beckmancoulter.com
  • Roche Diagnostics. cobas e 411 Analyzer Operator’s Manual. Accessed 2026-11-09. URL: https://diagnostics.roche.com
  • Abbott Diagnostics. ARCHITECT i2000SR System Specifications. Accessed 2026-11-09. URL: https://www.corelaboratory.abbott
  • Clinical and Laboratory Standards Institute (CLSI). EP05-A3 (Precision), EP06 (Linearity), EP07 (Interference), EP17-A2 (Detection Capability). Accessed 2026-11-09.
  • Occupational Safety and Health Administration (OSHA). 29 CFR 1910.1030: Bloodborne Pathogens Standard. Accessed 2026-11-09.

Follow CASRAI

Research-administration guidance, standards updates and independent tool reviews.

Ask CASRAI · free to try

Ask about Immunoassay Analyzer: Types, Specs, and Selection

2 free questions a day, no account.

An AI assistant for research: funder rules, compliance, methods and publishing. It links the sources behind its answers and labels answers that come from a web search.

Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.

Works on this site and inside Claude, Cursor and the AI tools you already use.

Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays open to read, with no account and no card.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →